Calcipotriol/Betamethasone Sandoz 50/500

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg; Calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg

Available from:

Sandoz New Zealand Limited

Pharmaceutical form:

Topical ointment

Composition:

Active: Betamethasone dipropionate 0.643 mg/g equivalent to betamethasone 0.50mg Calcipotriol monohydrate 0.0522 mg/g equivalent to calcipotriol 0.050mg Excipient: D-alpha Tocoferol Liquid paraffin Oleyl alcohol White soft paraffin

Prescription type:

Prescription

Therapeutic indications:

Calcipotriol and betamethasone ointment is indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy in patients 18 years and older.

Product summary:

Package - Contents - Shelf Life: Tube, aluminium, with PP or PE cap - 30 g - 18 months from date of manufacture stored at or below 25°C protect from light 12 months opened stored at or below 25°C protect from light

Authorization date:

2020-05-29